Jefferies sets INR 10,350 target for Apollo Hospitals stock
Published on 10/14/2026 at 13:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults and valuation markers
- On October 1, 2026, Jefferies set an INR 10,350 target for Apollo Hospitals stock.
- Consolidated net profit rose 38.40 percent to converted INR 6.10 billion in fiscal 2027's first quarter.
- Apollo Hospitals stock was at INR 7,824.00 on October 14, 2026 at 3:29 p.m. IST, down 0.60 percent versus the NSE close of October 13, 2026 at INR 7,871.00.
- The stock traded at a P/E ratio of 53.84 on October 14, 2026.
On October 1, 2026, Business Today reported that Jefferies set an INR 10,350 target for Apollo Hospitals. The target stands 32.30 percent above the NSE price of INR 7,824.00. Apollo Hospitals stock was last at INR 7,824.00 on NSE on October 14, 2026 at 3:29 p.m. IST, down 0.60 percent versus the NSE close of INR 7,871.00.
Revenue reaches INR 70.44 billion
Informed lists consolidated revenue from operations at converted INR 70.44 billion in the first quarter of fiscal 2027, up 20.60 percent from the year-earlier quarter. Consolidated net profit rose 38.40 percent to converted INR 6.10 billion, while earnings before interest, taxes, depreciation and amortization reached converted INR 11.41 billion.
The operating figures add a fundamental counterweight to the target discussion: revenue growth exceeded profit growth in percentage terms, while the reported net margin reached 8.70 percent in the first quarter of fiscal 2027.
Shares sit 13.74 percent below high
The NSE price of INR 7,824.00 stood within the 52-week range of INR 6,696.50 to INR 9,070.50 on October 14, 2026. That places the stock 13.74 percent below its 52-week high and 16.84 percent above its 52-week low.
Global Banking and Finance identifies Apollo Hospitals Enterprise Limited as APOLLOHOSP.NS on the NSE under ISIN INE437A01024, confirming the listing used for the market comparison.
Valuation and November date
Apollo Hospitals carried a market capitalization of INR 1.1 trillion and a P/E ratio of 53.84 on October 14, 2026. The dividend yield was 0.00 percent in the same quote.
Informed lists November 4, 2026 as the next board meeting date, with financial results on the agenda. That date gives the valuation figures a defined near-term event marker.
Comparison with peers
Apollo Hospitals (NSE, INR): minus 0.60 percent, P/E 53.84, market capitalization INR 1.1 trillion
Max Healthcare (NSE, INR): minus 0.99 percent, P/E 57.18, market capitalization INR 829.7 billion
Fortis Healthcare (NSE, INR): minus 0.85 percent, P/E 54.03, market capitalization INR 566.2 billion
Target leaves a wide gap
Jefferies' INR 10,350 target leaves a 32.30 percent gap above the latest NSE price, while Apollo Hospitals trades at a lower P/E ratio than Max Healthcare and a similar multiple to Fortis Healthcare. The combination of first-quarter growth and a scheduled November board meeting keeps operating results and valuation on the same timetable.
The further course of trading is shown by the continuously updated real-time quote of Apollo Hospitals stock.
Apollo Hospitals market data
- Company: Apollo Hospitals Enterprise Limited
- ISIN: INE437A01024
- Ticker: APOLLOHOSP.NS
- Primary exchange: NSE
- Price NSE (as of October 14, 2026, 3:29 p.m. IST): INR 7,824.00
- Change versus NSE close: minus 0.60 percent
- NSE close (October 13, 2026): INR 7,871.00
- Market capitalization: INR 1.1 trillion (as of October 14, 2026)
- 52-week range: INR 6,696.50-9,070.50 (as of October 14, 2026)
- Sector / Industry: Healthcare / Hospitals
Market context: Market report BSE Sensex.
